"Short-term Outcome in STEMI Patients Undergoing Primary PCI: A Comparative Study Between Rural and Urban Communities at Assiut University."
"Short-term Outcome of Patients From Rural Versus Urban Communities Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction"
1 other identifier
observational
162
0 countries
N/A
Brief Summary
this study aims to assess the short-term (3-month) clinical and echocardiographic outcomes of primary PCI among STEMI patients from rural versus urban areas in Upper Egypt. A special focus will be placed on identifying predictors of MACE. The findings may offer valuable insight into optimizing STEMI care pathways and support the development of regional STEMI networks across Egypt.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2025
CompletedStudy Start
First participant enrolled
August 15, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
August 22, 2025
August 1, 2025
1.2 years
July 28, 2025
August 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of major adverse cardiovascular events (MACE) among STEMI patients undergoing primary percutaneous coronary intervention (PCI),
Unite of measurement : Number of patients experiencing MACE (% of total)
3 month
Interventions
A catheter-based invasive procedure used to open blocked coronary arteries in patients presenting with ST-elevation myocardial infarction (STEMI).
Eligibility Criteria
patients Confirmed diagnosis of ST-segment elevation myocardial infarction (STEMI) based on ECG and cardiac biomarkers.
You may qualify if:
- \. Adults aged ≥18 years. 2. Confirmed diagnosis of ST-segment elevation myocardial infarction (STEMI) based on ECG and cardiac biomarkers.
- \. Underwent primary percutaneous coronary intervention (PCI) within the study period.
- \. Known and verified residential address classified as rural or urban based on official definitions (e.g., UK or WHO classification).
- \. Informed consent obtained
You may not qualify if:
- Non-STEMI or unstable angina cases.
- Patients who received fibrinolytic therapy instead of PCI.
- Transfer from another facility after more than 12 hours of symptom onset.
- Patients with previous revascularization (e.g., CABG or PCI within the last 6 months).
- Incomplete clinical data or unknown residential location.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 28, 2025
First Posted
August 22, 2025
Study Start
August 15, 2025
Primary Completion (Estimated)
October 15, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
August 22, 2025
Record last verified: 2025-08